The estimated Net Worth of Brian B Hansen is at least $5.95 Milion dollars as of 27 November 2023. Mr. Hansen owns over 406 units of Tandem Diabetes Care Inc stock worth over $545,107 and over the last 9 years he sold TNDM stock worth over $0. In addition, he makes $5,399,900 as Chief Commercial Officer a Executive Vice President at Tandem Diabetes Care Inc.
Brian has made over 34 trades of the Tandem Diabetes Care Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 406 units of TNDM stock worth $17,348 on 27 November 2023.
The largest trade he's ever made was exercising 50,000 units of Tandem Diabetes Care Inc stock on 29 January 2020 worth over $943,000. On average, Brian trades about 6,468 units every 38 days since 2016. As of 27 November 2023 he still owns at least 12,757 units of Tandem Diabetes Care Inc stock.
You can see the complete history of Mr. Hansen stock trades at the bottom of the page.
Brian B. Hansen is the Chief Commercial Officer, Executive Vice President of Tandem Diabetes Care Inc. Mr. Hansen has served as our Executive Vice President and Chief Commercial Officer since February 2016. Prior to joining us, Mr. Hansen served from September 2014 as Chief Commercial Officer of Adaptive Biotechnologies Corp. From May 2013 to September 2014, Mr. Hansen served as Head of Commercial, Sales and Marketing, of Genoptix, a Novartis Company. From December 2005 to February 2013, he served in various roles of increasing responsibility at Gen-Probe, Inc., a medical diagnostics company, most recently serving as Senior Vice President, Global Sales and Services from January 2012 to February 2013. Mr. Hansen received a B.S. in Business Administration from the University of Missouri-Columbia, and an M.B.A. from the School of Business at San Diego State University.
As the Chief Commercial Officer a Executive Vice President of Tandem Diabetes Care Inc, the total compensation of Brian Hansen at Tandem Diabetes Care Inc is $5,399,900. There are 2 executives at Tandem Diabetes Care Inc getting paid more, with John Sheridan having the highest compensation of $10,560,900.
Brian Hansen is 52, he's been the Chief Commercial Officer a Executive Vice President of Tandem Diabetes Care Inc since 2016. There are 12 older and 10 younger executives at Tandem Diabetes Care Inc. The oldest executive at Tandem Diabetes Care Inc is Dick Allen, 75, who is the Lead Independent Director.
Brian's mailing address filed with the SEC is 12400, High Bluff Drive, San Diego, San Diego County, California, 92130, United States.
Over the last 11 years, insiders at Tandem Diabetes Care Inc have traded over $154,253,951 worth of Tandem Diabetes Care Inc stock and bought 4,118,443 units worth $11,618,906 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Douglas A Roeder a Nicole Vitullo. On average, Tandem Diabetes Care Inc executives and independent directors trade stock every 9 days with the average trade being worth of $885,878. The most recent stock trade was executed by Shannon Marie Hansen on 15 August 2024, trading 1,968 units of TNDM stock currently worth $84,093.
tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan
Tandem Diabetes Care Inc executives and other stock owners filed with the SEC include: